20314 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
Alkanoylamino benzamide aniline HDAC inhibitor compounds
#1202Synergistic pharmaceutical combination for the treatment of cancer
#1203Method of treating polycystic kidney diseases with ceramide derivatives
#1204Treatment of neurofibromatosis with radicicol and its derivatives
#1205COMBINATIONS OF JAK INHIBITORS
#1206Treatment of osteoarthritis pain
#1207Anti-viral compounds
#1208PHARMACEUTICAL FOAM
#1209Kallikrein 7 modulators
#1210Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1211TREATMENT OF PROLIFERATIVE DISORDERS
#1212Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
#1213BIS(THIO-HYDRAZIDE AMIDE) FORMULATION
#1214Substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
#1215STABLE PHARMACEUTICAL FORMULATION FOR A DPP-IV INHIBITOR
#1216Phenoxy-pyrrolidine derivative and its use and compositions
#1217CANNABINOID RECEPTOR MODULATOR
#1218Pyrrolidine compounds
#1219IAP BIR DOMAIN BINDING COMPOUNDS
#1220Methods and compositions for modulating P300/CBP activity
#1221COMPOSITIONS AND METHODS FOR COATING ORTHOPEDIC IMPLANTS
#1222Pyrrolinone derivative and pharmaceutical composition comprising the same
#1223Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
#1224METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS
#1225Coumarin derivatives useful as TNFα inhibitors
#1226Methods for treating anxiety
#1227Use of parthenolide derivatives as antileukemic and cytotoxic agents
#1228TREATMENT OF EXCESS SEBUM PRODUCTION
#1229Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#1230Angiogenesis-modulating compositions and uses
#1231INHIBITORS OF CYCLIC AMP PHOSPHODIESTERASES
#1232USE OF PIPERINE AND DERIVATIVES THEREOF FOR THE THERAPY OF NEUROLOGICAL CONDITIONS
#1233Coumarin derivatives useful as TNFα inhibitors
#1234Antibacterial agents
#1235Method and Composition for Treating Alzheimer's Disease and Dementias of Vascular Origin
#1236INHIBITION OF P38 KINASE ACTIVITY BY ARYL UREAS
#1237STABLE ATORVASTATIN FORMULATIONS
#1238Compositions and methods for the treatment of overactive bladder
#1239Ischemic disorder or disease inhibitors
#1240Inhibitors of store operated calcium release
#1241METHODS AND COMPOSITIONS FOR REDUCING INFLAMMATION AND TREATING INFLAMMATORY DISORDERS
#1242Therapy for the treatment of disease
#1243Melanocortin receptor agonists
#1244Phenylacetic acid inhibitors of cyclooxygenase
#1245Methods and compositions for treating HIV infections
#1246Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
#1247Use of PDE7 inhibitors for the treatment of movement disorders
#1248Modulators of aldehyde dehydrogenase and methods of use thereof
#1249PHARMACEUTICAL COMPOSITIONS COMPRISING 3,5-DIAMINO-6-(2,3-DICHLOPHENYL)-1,2,4-TRIAZINE OR R(-)-2,4-DIAMINO-5-(2,3-DICHLOROPHENYL)-6-FLUOROMETHYL PYRIMIDINE AND AN NK1
#1250Phenyl substituted maleimides as medicaments for blocking degenerative tissue damages by inhibiting MPT
#1251NOVEL COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#1252Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
#1253Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#1254Methods and compositions for the treatment of estrogen-dependent hyperproliferative uterine disorders
#1255Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
#1256Method for the treatment and prevention of ocular disorders
#1257Oligomer-opioid agonist conjugates
#1258Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
#1259Inhibiting serum response factor (SRF) to improve insulin sensitivity
#1260Method for treating pulmonary diseases using rho kinase inhibitor compounds
#1261Therapy for the treatment of disease
#1262Compounds having analgesic and/or immunostimulant activity
#1263Antibiotic combinations for providing total solution to the treatment of infections
#1264COUMARIN COMPOUNDS AND THEIR USE FOR TREATING VIRAL INFECTION
#1265ATORVASTATIN FORMULATION
#1266METHODS OF TREATING SCHIZOPHRENIA
#12673-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
#1268THERAPY FOR THE TREATMENT OF DISEASE
#1269Compositions and Methods for Treating Female Sexual Dysfunction
#1270Substituted gamma lactams as therapeutic agents
#1271Oxazole and thiazole compounds as beta-catenin modulators and uses thereof
#1272THERAPEUTIC INHIBITOR OF VASCULAR SMOOTH MUSCLE CELLS
#1273Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents
#1274GnRH analogue formulations
#1275Darifenacin for use in the treatment of urgency induced by overactive bladder
#1276Organic Compounds
#1277Topical bioadhesive formulations
#1278Compositions and methods for treatment of diabetic retinopathy
#1279Methods and compositions for the treatment of cancer using benzopyrone-type PARP inhibitors
#1280Process for preparation of (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
#1281COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA
#1282Methods of treating fatty liver disease
#1283Compounds, their preparation and use
#1284METHODS OF USING AS ANALGESICS 1-BENZYL-1-HYDROXY-2,3-DIAMINO-PROPYL AMINES, 3-BENZYL-3-HYDROXY-2-AMINO-PROPIONIC ACID AMIDES AND RELATED COMPOUNDS
#1285Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
#1286Multikinase inhibitors for use in the treatment of cancer
#1287Method of regulating glucose metabolism, and reagents related thereto
#1288M3 MUSCARINIC RECEPTOR ANTAGONISTS FOR TREATMENT OF M3 MUSCARINIC RECEPTOR-EXPRESSING TUMORS
#1289THERAPY FOR COMPLICATIONS OF DIABETES
#1290Inhibitors for steroid response elements and related methods
#1291Novel Pharmaceutical
#1292Compositions and methods for the diagnosis and treatment of tumor
#12933-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
#1294Methods for treating an ulcer of the small intestine and stomach
#1295Pulsatile gastric retentive dosage forms
#1296Cannabinoid receptor modulator
#1297Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
#1298Cross-media voice mail notification and delivery
#12993-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity
#1300Compositions and methods for enhanced gastrointestinal stability of oligopeptides and polypeptides
#1301COMBINATION OF AN DPP-IV INHIBITOR AND A PPAR-ALPHA COMPOUND
#1302Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts
#1303Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
#1304Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
#1305Staurosporine derivatives for use in alveolar rhabdomyosarcoma
#1306Ingestible Plaque Eliminator for Animals
#1307Ingestible Malodor Eliminator for Animals
#1308Physiologically active substances
#1309Physiologically active substances
#1310Compounds inhibiting the binding of sap for treating osteoarthritis
#1311Pharmaceutical compositions
#1312Nanoparticulate statin formulations and novel statin combinations
#1313IAP BIR domain binding compounds
#1314Organic compounds
#1315PHARMACEUTICAL USE OF NITRIC OXIDE, HEME OXYGENASE-1 AND PRODUCTS OF HEME DEGRADATION
#1316Methods of treating diabetes mellitus
#1317Compositions and methods for treating or preventing imflammatory diseases
#1318Methods of Treating Cognitive Impairment and Dementia
#1319N-sulfonylurea apoptosis promoters
#1320Proton pump inhibitors
#1321Wortmannin analogs and methods of using same
#1322METHODS FOR ENHANCING COGNITIVE FUNCTION
#1323Compositions and methods for treating or preventing inflammatory diseases
#1324Inhibitors of cyclin dependent kinases and their use
#1325Use of fullerenes for the treatment of mast cell and basophil-mediated disease
#1326Method for treating neovascularization
#1327METHODS FOR DESIGNING PARP INHIBITORS AND USES THEREOF
#1328Medical Use of Bilirubin and its Structural Analogues
#1329IAP BIR domain binding compounds
#1330Synthesis of UDP-glucose: -acylsphingosine glucosyltransferase inhibitors
#1331Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound
#1332Cannabinoid receptor modulator
#1333COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE
#1334PHARMACEUTICAL COMPOSITION AS SOLID DOSAGE FORM AND METHOD FOR MANUFACTURING THEREOF
#1335Cancer treatment with compounds inhibiting PKC alpha
#1336Medicaments Comprising Carbonyl Compounds, And The Use Thereof
#1337Substituted gamma lactams as therapeutic agents
#1338Preventives/remedies for stress urinary incontinence and method of screening the same
#1339Substituted gamma lactams as therapeutic agents
#1340Method of treatment
#1341Uses of polypeptides
#1342Preparation of antibody or an antibody fragment-targeted immunoliposomes for systemic administration of therapeutic or diagnostic agents and uses thereof
#1343Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
#1344Selenophene anti-tumor agents
#1345USE OF BENZO-HETEROARYL SULFAMIDE DERIVATIVES FOR THE TREATMENT OF SUBSTANCE ABUSE AND ADDICTION
#1346Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
#1347Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
#1348Antiparasitic artemisinin derivatives (endoperoxides)
#1349Treatment of conditions that present with low bone mass by continuous combination therapy with selective prostaglandin ep4 receptor agonists and an estrogen
#1350Pyrrole derivatives as gonadotropin releasing hormone (gnrh) antagonists
#1351New Method for Treating Urinary Disorders
#1352Agents For Treating Neurodegenerative Diseases
#1353Combination of a dpp IV inhibitor and an antiobesity or appetite regulating agent
#1354Therapeutic inhibitor of vascular smooth muscle cells
#1355Therapeutic inhibitor of vascular smooth muscle cells
#1356Method of regulating glucose metabolism, and reagents related thereto
#1357Atorvastatin formulation
#1358Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors
#1359Cannabinoid receptor modulator
#1360Bis(thio-hydrazide amide) formulation
#1361Agents for treating neurodegenerative diseases
#1362Pharmaceutical foam
#1363Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds
#1364Compositions for the treatment of overactive bladder
#1365Substituted 2-arylmethylene-n-aryl-n'aryl-malonamides and analogs as activators of caspases and inducers of apoptosis
#1366Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease
#1367Migrastatin analogs and uses thereof
#1368Use of progesterone receptor modulators
#1369Antiparasitic artemisinin derivatives (endoperoxides)
#1370Degradation fragments
#1371Treatment of hot flashes, impulse control disorders and personality change due to a general medical condition
#1372Fungicidal effect by regulating signal transduction pathways
#1373Antiparasitic artemisinin derivatives (endoperoxides)
#1374Conjugates formed from polymer derivatives having particular atom arrangements
#1375Combination therapy for the treatment of obesity
#1376Method for treating neovascularization
#1377Beta-blockers having antioxidant and no-donor activity
#1378Pharmaceutical composition as solid dosage form and method for manufacturing thereof
#1379Treatment of pervasive developemental disorders with norepinephrine reuptake inhibitors
#1380Physiologically active substances
#1381Therapeutic methods for type I diabetes
#13823,4-disubstituted coumarin and quinolone compounds
#1383Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
#1384Dual controlled release dosage form
#1385NKantagonists
#1386Crystalline form of a drug
#1387Wortmannin analogs and methods of using same
#1388Pyrrolidin-2-one derivatives as inhibitors of factor xa
#1389Pyrrolidin-2-one derivatives as inhibitors of factor xa
#1390Novel dosage form
#1391Compounds useful for the treatment of cancer, compositions thereof and methods therewith
#1392Vesicant treatment with phenyl-thiophene type vitamin d receptor modulators
#1393Treating seizures using ice inhibitors
#1394Pharmaceutical foam
#13951,5-Diaryl-pyrrole-3-carboxamide derivatives and their use as cannabinoid receptor modulators
#1396Combination of an dpp-iv inhibitor and a ppar-alpha compound
#1397Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#1398Methods for inhibiting bone loss
#1399Signals and molecular species involved in senescence
#1400Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
#1401Bioactive substance
#1402N-sulfonylurea apoptosis promoters
#1403Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis
#1404Wortmannin analogs and methods of using same in combination with chemotherapeutic agents
#1405Method for treating urinary disorders
#1406Selenophene compounds
#1407Methods of treating cancer and the pain associated therewith using endothelin antagonists
#1408Compounds useful for the treatment of cancer, compositions thereof and methods therewith
#1409Prevention and treatment of cardiovascular pathologies
#1410Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients
#1411Coumarin derivatives useful as TNFα inhibitors
#1412Therapeutic agent
#1413Cancer treatment with compounds inhibiting PKC alpha
#1414Acetamides and benzamides that are useful in treating sexual dysfunction
#1415Novel physiologically active substances
#1416Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
#1417Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
#1418Use of parthenolide derivatives as antileukemic and cytotoxic agents
#1419Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
#1420Nitrogen-containing compounds
#1421Compositions and methods for treating or preventing inflammatory diseases
#1422Treating infectious diseases using ice inhibitors
#1423Fibrosis inhibitor
#1424Synthesis of UDP-glucose: -acylsphingosine glucosyltransferase inhibitors
#1425Pharmaceutical combinations
#1426Methods for assessing, improving, or maintaining urogenital health in postmenopausal woman
#1427Methods of treatment using an EP2 selective receptor agonist
#1428Selenophene anti-tumor agents
#14293-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
#1430Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
#1431Histamine-3 receptor ligands for diabetic conditions
#1432Methods of treating cancer and the pain associated therewith using endothelin antagonists
#1433Methods of treating cancer and the pain associated therewith using endothelin antagonists
#1434Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
#1435Method of treating certain cancers using an estrogen agonist/antagonist
#1436Heterocyclic thioester and ketone hair growth compositions and uses
#1437Angiogenesis-modulating compositions and uses
#1438Treatment of BPH
#1439Coumarin derivatives useful as TNFα inhibitors
#1440Synthesis of UDP-glucose: -acylsphingosine glucosyltransferase inhibitors
#1441Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
#1442Treatment for a attention-deficit hyperactivity disorder
#1443Charged ion channel blockers and methods for use
#1444Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs
#1445Compositions and methods for treating HCV
#1446Compositions and methods for the treatment of epilepsy
#1447Antiprotozoal amidine compounds
#1448Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
#1449ER-stress inducing compounds and methods of use thereof